Time to Development of Anemia and Predictors among HIV-Infected Patients Initiating ART at Felege Hiwot Referral Hospital, Northwest Ethiopia: A Retrospective Follow-Up Study
Table 2
Baseline clinical, biological and ART information of HIV-positive adults at initiation of HAART at Felege Hiwot Referral Hospital (January 2012 to December 2017) ().
Variables
Category
(%)
Weight at baseline
≤60
187 (38.2)
>60
303 (61.8)
BMI
Overweight
60 (12.2)
Normal
288 (58.8)
Underweight
142 (29.0)
Functional status at baseline
Working
224 (45.7)
Ambulatory
202 (41.2)
Bedridden
64 (13.1)
WHO staging at baseline
Stage 1
94 (19.2)
Stage 2
289 (59.0)
Stage 3
88 (18.0)
Stage 4
19 (3.9)
Past prophylaxis
No
235 (48.0)
Yes
255 (52.0)
CD4 count at baseline
<200
142 (29.0)
≥200
348 (71.0)
Baseline ART regimen
1a = (30) d4t(30)/-3Tc-NVP
6 (1.2)
1a = (40) d4t(40)/-3Tc-NVP
68 (13.9)
1b = (30) d4t(30)/-3Tc-EFV
101 (20.6)
1b = (40) d4t(40)/-3Tc-EFV
271 (55.3)
1c = AZT-3Tc-NVP
27 (5.5)
1d = AZT-3Tc-EFV
17 (3.5)
Nutritional status
Severe acute malnutrition ()
56 (11.4)
Moderate acute
69 (14.1)
Mild acute
179 (36.5)
Normal (BMI 18.5-24.9 kg/m2)
186 (38)
BMI: body mass index; d4t: stavudine; 3Tc: lamivudine; NVP: nevirapine; EFV: efavirenz; AZT: zidovudine.
